Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

GLP-1 agonists work by triggering the pancreas to produce more insulin, which reduces blood sugar levels in those with type 2 ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

‘Fat’ jabs, ‘skinny’ jabs, ‘anti-obesity’ medications – weight-loss drugs come with many names. A favourite amongst celebs ...

Discover the potential of weight loss injections like Ozempic and Wegovy in combating obesity and promoting a healthier lifestyle.

Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given ...

Health secretary Wes Streeting announced weight loss injections could be used to get people living with obesity "back to work" at full capacity.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

A surge in the use of GLP-1 drugs is among the reasons a new report projects a calorie intake decline of 10 quadrillion in ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...